INTIMATION FOR BODHIKA SEMINAR
26/6/2024
DEPARTMENT OF KAUMARABHRITYA
DISSERTATION TITLE : COMBINED EFFECT OF THRIKATUKADI MODAKA AND UDWARTHANA WITH THRIPHALA CHURNA ALONG WITH PRESCRIBED DIET IN THE MANAGEMENT OF EXOGENOUS OBESITY IN CHILDREN OF AGE GROUP 6 TO 12 YEARS.
Name of Guide : Dr LEKSHMI MK
DATE : 26/6/2024
Time : 2 pm
Venue : college auditorium
ABSTRACT
Body mass index greater than or equal to the
95th percentile for age and gender in children aged two years and
older is called obesity. Exogenous obesity caused by a caloric intake greater than the need to
meet the metabolic needs of the body. More than 39 million children are obese
all over the world.
In India 12.1% of males, 16% of females and 11.7%
children are obese. Obesity decreases the quality of life both in childhood and
adulthood. Children are prone to become obese due to the predominance of Kapha.
Kapha and Medas play major role in the samprapthi of obesity. The
interventional drug Thrikatukadimodaka possesses katu tiktha rasa, ruksha
theekshna guna and ushna veerya.
Thriphala churna which has medohara property is used for udwarthana. Both
helped in samprapthivighatana of exogenous obesity. The study is going on in
the OPD of Govt. Ayurveda College Hospital for Women and Children, Poojappura, as a clinical
trial with pre, post and post-follow up assessment. Children of both sex with
signs and symptoms of obesity coming under the age of 6-12 years attending O P
of Kaumarabhritya will be selected for the initial screening which includes
case taking along with assessment for obesity using the parameters BMI, Weight,
Mid arm circumference, Hip circumference, Abdominal circumference and Mid
-thigh circumference. Trial group will receive medicines and procedure along
with prescribed diet for a period of two months. Follow up will be done after
one month. Data will be collected and statistically analysed using Repeated
measures Anova.
Key words: Exogenous obesity, BMI, Thrikatukadi modaka, Thriphala churna, Udwarthana
SECOND PRESENTEE : Dr.ANUPAMA S
DISSERTATION TITLE : COMBINED EFFECT OF DHATRI PAYASYADI GHRITHA ALONG WITH DIETARY ADVICE IN UNDERNOURISHED CHILDREN OF AGE GROUP 3-6 YEARS.
DATE : 26/6/2024
Time : 2 .30 pm
Venue : college auditorium
Nutrition plays an
important role in the physical, mental and emotional development of children. Undernutrition
is widely recognised as a major health problem in developing countries of the
world. It is a condition in which there is inadequate consumption, poor
absorption or excessive loss of nutrients. It is defined as being underweight
for one’s age, too short for one’s age (stunting), dangerously thin for one’s
height(wasting), and deficient in vitamin and minerals (micronutrients) as an
outcome of insufficient food intake, inadequate care and infectious diseases.
It affects more than one third of world’s children making it the most damaging
form of malnutrition worldwide. It has critical consequences for physical and
cognitive growth and development in children. According to NFHS – 5 survey,
32.1% were having underweight and around 45% of deaths among children under 5
years of age are linked to undernutrition.
Ayurveda is mainly based
on preventive aspect first rather than curative. It explains the disease
‘Karshya’ which can be taken as the nutritional deficiency disorder where
weight loss (underweight) is the main feature.
A clinical study was
designed to evaluate the combined effect of Dhatripayasyadi Gritha along with
dietary advice in undernourished children of age group 3 to 6 years. The study
was conducted as an interventional, pre and post-test. It was carried out in OP
Department of Kaumarabhritya, Govt. Ayurveda College Hospital for Women &
Children, Thiruvananthapuram. Children of both sex satisfying the inclusion
criteria of weight for age less than 2 standard deviation from median reference
according to National Centre for Health Statistics (NCHS) was included in the
study, screened and assessed using case proforma and anthropometric
measurements. Then the trial drug Dhatripayasyadi Gritha was given in a dose of
3.5ml twice daily with lukewarm water as anupana along with proper dietary
advice for a period of 2 months with follow up of 1 month. Weight, BMI, mid
upper arm circumference, chest circumference and clinical parameters grading were
done before treatment, after treatment and after follow up. Data will be
collected and statistically analysed using Paired t test and Wilcoxon sign rank
test.
Keywords :
Dhatripayasyadi Ghrita, Karshya, Undernutrition, Weight.
NAME OF THIRD PRESENTEE : Dr.LAKSHMI N MENON
DISSERTATION TITLE : EFFECT OF BHARNGYADI KASHAYA AS ARKA IN BRONCHITIS AMONG CHILDREN OF THE AGE GROUP 3-10 YEARS
DATE : 26/6/2024
Time : 3 pm
Venue : college auditorium
ABSTRACT
Bronchitis is a condition in which
the airways in the lungs, called bronchial tubes, become inflamed and cause coughing,
often with mucus. Bronchitis can be acute (short-term) or chronic
(long-term).Acute bronchitis is an acute respiratory infection that is
manifested by cough and at times, sputum production that lasts for no more than
3 weeks. Viral infections, such as the cold or flu, are usually the cause, and
most people recover after a few days or weeks. Occasionally, acute bronchitis
can be caused by a bacterial infection. Chronic bronchitis is defined as a productive cough that lasts at least
three months, with recurring bouts occurring for at least two consecutive
years. Signs and symptoms of both acute and
chronic bronchitis include, persistent cough, which may produce mucus,
wheezing, low fever and chills, feeling of tightness in the chest, sore
throat, body aches, breathlessness, headache and blocked nose and sinuses.
A clinical study is designed to evaluate
the effect of Bharngyadi Kashaya as
Arka in Bronchitis among children of the age group 3-10 years. The formulation
Bharngyadi Kashaya is explained in Jwararoga
adhikara of Sahasrayoga- by M
Narayana Vaidyar, Edakkad. It is prepared as per Arka Kalpana. Arka prakasa of Ravana, opines that it has more potency
in comparison to the other kalpanas. Moreover, due to its increased potency,
reduced dose, better shelf life, easy absorption, fast action and patient
compliance, it would be the best choice among paediatric population.
The study will be conducted as an
interventional pre and post-test. Children of both sex of age group 3-10 years
satisfying the inclusion criteria will be selected for the study. The trial
drug, Bharngyadi Kashaya as Arka will be administered for a period of 21 days
in a dose of 5ml to children of 3-5 years and 10 ml for 6-10 years with equal
amount of lukewarm water. All children in the study will be assessed each week
using subjective symptomatic grading of clinical features by using Bronchitis
Severity Score (BSS), PEFR and oxygen saturation. The blood parameters (TC, DC,
ESR, AEC) will be assessed before and after the interventional period. The data collected will be analysed statistically using
Wilcoxon signed rank test or Paired t test depending on the pattern of
distribution.
KeKeywords:
Bronchitis, Bharngyadi
Kashaya, Arka, Bronchitis Severity Score.
No comments:
Post a Comment